ArticleHardwareX2025
AnyBio - An easy off-the-shelf masked stereolithography bioprinter conversion combined with radical-scavenging strategies.
Article in HardwareX, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the last two decades 3D bioprinting has gained momentum to fabricate tissue mimicking constructs serving as tissue models, animal-free drug screening platforms and tissue replacements for regenerative medicine. Recently, the focus has shifted towards the development of light-based bioprinting methods due to its high accuracy and absence of nozzle-induced shear stress on printed cells. However, light-based bioprinting equipment can be costly and photo-sensitive materials difficult to optimize. In this work, we present the conversion of a masked stereolithography printer into a heated, humidified, and easily sterilizable bioprinter, with minimal financial investment (<350 € including purchase of the printer). We provide instructions on how to optimize bioinks and printing conditions and explore novel bioresin additives utilizing cell-friendly photon absorption and radical scavenging strategies. As a proof of concept, we demonstrate the compatibility of our method for the ability of our printer to produce complex and perfusable architectures as well as successful cell printing with high post-printing viability. With this we aim to contribute to accessibility of both hardware and protocols to easily implement bioprinting with minimal barriers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.